Clinical Trial: Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title:
Brief Summary: This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta.
Detailed Summary: This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta dispositioned for a scheduled delivery. The primary outcome will be assessed by comparing the composite neonatal morbidity and composite maternal morbidity between the two groups (delivery at 34 versus 36 weeks gestational age).
Sponsor: The University of Texas Health Science Center, Houston
Current Primary Outcome:
- Composite neonatal morbidity [ Time Frame: Within 72 hours of newborn discharge ]
- Maternal neonatal morbidity [ Time Frame: Within 72 hours of patient discharge ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: The University of Texas Health Science Center, Houston
Dates:
Date Received: December 16, 2015
Date Started: March 2016
Date Completion:
Last Updated: February 11, 2016
Last Verified: February 2016
